Drug Type Synthetic peptide |
Synonyms PL 035, PL035 |
Target |
Action inhibitors |
Mechanism TSLP inhibitors(Thymic stromal lymphopoietin inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allergic asthma | Discovery | China | 29 Feb 2024 | |
Dermatitis | Discovery | China | 29 Feb 2024 |